小さな分子の高度に特異的な細胞内ユビキチン化

Weicheng Li¹, Enrique M Garcia-Rivera^2,3, Dylan C Mitchell⁴

¹Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Nature chemical biology

|August 21, 2025

まとめ

研究者らはUBRD1732という新しい分子を発見しユビキチン-プロテアゾームシステムを阻害しますこの発見は,タンパク質の改変と分解の経路をターゲットにする新しい方法を示唆しています.

科学分野:

生物化学
分子生物学
細胞生物学

背景:

ユビキチンは,エウカリオットにおける重要な翻訳後の変容体であり,しばしばプロテアソーム経由でタンパク質の分解をシグナルする.
Ubiquitin-proteasome system (UPS) は,細胞タンパク質の安定化と調節に不可欠である.

研究の目的:

ユビキチン-プロテアソームシステムを調節する新しい小分子を特定する.
新しい分子 BRD1732の作用と細胞効果を研究する

主な方法:

多様性指向の合成ライブラリをスクリーニングする.
タンパク質のユビキチン化とプロテアソーム活性を評価する細胞測定法.
遺伝的および生化学的アプローチを用いたステレオ特異性およびE3リガゼ依存性研究.

主要な成果:

BRD1732という新しい小分子が細胞内で直接 ubiquitinated されていることが判明しました
BRD1732の不活性なユビキチン単体とポリユビキチン鎖の蓄積は,広範なUPS抑制につながった.
BRD1732のユビキチン化とその細胞毒性はステレオ特異的で,RNF19A/ B E3リガゼとUBE2L3 E2酵素に依存していた.

結論:

BRD1732はユビキチネーションの仕組みを乗っ取った新種の分子です
この研究は,小分子がトランスレーション後の改変を誘導する可能性を実証している.
この発見はUPSを標的とした新しい治療戦略の開発の道を開きます.

さらに関連する動画

09:00

Detection of Protein Ubiquitination

Published on: August 19, 2009

43.0K

09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

2.7K

関連する概念動画

02:58

Regulated Protein Degradation

7.6K

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

7.6K

01:13

The Proteasome

1.1K

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

1.1K

02:04

Covalently Linked Protein Regulators

7.1K

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....

7.1K

01:15

Receptor Downregulation in MVBs

2.1K

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

2.1K

01:38

Intralumenal Vesicles and Multivesicular Bodies

3.7K

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...

3.7K

01:32

Export of Misfolded Proteins out of the ER

3.9K

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...